Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
New hope for stroke patients: which blood thinner works best after emergency treatment?
Disease control CompletedThis study tested two blood thinners—tirofiban and aspirin—in 240 stroke patients who also had a severe blockage in the neck artery. The goal was to see which drug better prevents the artery from reclosing after emergency surgery, while also checking for bleeding risks. Results w…
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Mediterranean diet shows promise in fighting fatty liver
Disease control CompletedThis study looked at whether a Mediterranean diet, with or without added exercise, could help people with a type of fatty liver disease called MASLD. The goal was to see if the diet could reduce fat and scarring in the liver. 96 adults took part, and researchers used special MRI …
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New antibiotic shows promise against superbug blood infections
Disease control CompletedThis study tested whether an older antibiotic, temocillin, works as well as the standard treatment meropenem for bloodstream infections caused by drug-resistant bacteria. 334 adults with these infections were randomly assigned to receive one of the two antibiotics for 7 to 14 day…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC